scispace - formally typeset
J

Jing Chen

Researcher at Centers for Disease Control and Prevention

Publications -  5
Citations -  43

Jing Chen is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Vaccination & Seroconversion. The author has an hindex of 3, co-authored 5 publications receiving 24 citations.

Papers
More filters
Journal ArticleDOI

Spatio-temporal cluster and distribution of human brucellosis in Shanxi Province of China between 2011 and 2016.

TL;DR: The HB incidence in Shanxi had a significantly high correlation with the number of the cattle or sheep especially in the northern Shanxi, and showed unique spatio-temporal clustering.
Journal ArticleDOI

Human adenovirus species C recombinant virus continuously circulated in China.

TL;DR: Wang et al. as mentioned in this paper performed genomic and bioinformatics analysis of two HAdV-C strains (strain SX-2000-140 and strain SX-2004-327) that were isolated from the feces of two healthy children in Shanxi province of China in 2000 and 2004, respectively.
Journal ArticleDOI

Monitoring and evaluation of intervals from onset of fever to diagnosis before "1-3-7" approach in malaria elimination: a retrospective study in Shanxi Province, China from 2013 to 2018.

TL;DR: The current “1-3-7” approach is well executed in Shanxi Province, but delays intervals observed in case finding before 1- 3-7 approach occurred in all levels of facilities in ShanXi Province, which imply that more efforts are highlighted for timely case finding.
Journal ArticleDOI

Incidence of influenza virus infections confirmed by serology in children and adult in a suburb community, northern China, 2018‐2019 influenza season

TL;DR: In mainland China, seasonal influenza disease burden at community level is unknown and the incidence rate of influenza virus infections in the community is difficult to determine due to the lack of well‐defined catchment populations of influenza‐like illness surveillance sentinel hospitals.
Posted ContentDOI

Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine in High-Risk Occupational Population: a randomized, parallel, controlled clinical trial

TL;DR: Wang et al. as discussed by the authors conducted a randomized, parallel, controlled clinical trial for assessment of the immunogenicity and safety of an inactivated SARS-CoV-2 vaccine, aiming to determine an appropriate vaccination interval for high-risk occupational population.